| The functional gastrointestinal disorders and the Rome III process DA Drossman gastroenterology 130 (5), 1377-1390, 2006 | 4415 | 2006 |
| Functional gastroduodenal disorders J Tack, NJ Talley, M Camilleri, G Holtmann, P Hu, JR Malagelada, ... Gastroenterology 130 (5), 1466-1479, 2006 | 2790 | 2006 |
| Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota GR Locke 3rd, NJ Talley, SL Fett, AR Zinsmeister, LJ Melton 3rd Gastroenterology 112 (5), 1448-1456, 1997 | 2598 | 1997 |
| Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report P Malfertheiner, F Megraud, C O'morain, APS Hungin, R Jones, A Axon, ... Alimentary pharmacology & therapeutics 16 (2), 167-180, 2002 | 2104 | 2002 |
| Rome III The functional gastrointestinal disorders A Drossman Gastroenterology 130, 1377-1556, 2006 | 1896* | 2006 |
| Functional gastroduodenal disorders NJ Talley, V Stanghellini, RC Heading, KL Koch, JR Malagelada, ... Gut 45 (suppl 2), II37-II42, 1999 | 1836 | 1999 |
| Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised … K Fukase, M Kato, S Kikuchi, K Inoue, N Uemura, S Okamoto, S Terao, ... The Lancet 372 (9636), 392-397, 2008 | 1191 | 2008 |
| An evidence-based position statement on the management of irritable bowel syndrome LJ Brandt, WD Chey, AE Foxx-Orenstein, LR Schiller, PS Schoenfeld, ... The American journal of gastroenterology 104, S1-S35, 2009 | 1047* | 2009 |
| Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. NJ Talley, RG Shorter, SF Phillips, AR Zinsmeister Gut 31 (1), 54-58, 1990 | 1046 | 1990 |
| Dyspepsia and dyspepsia subgroups: a population-based study NJ Talley, AR Zinsmeister, CD Schleck, LJ Melton III Gastroenterology 102 (4), 1259-1268, 1992 | 996 | 1992 |
| Prevalence of Barrett’s esophagus in the general population: an endoscopic study J Ronkainen, P Aro, T Storskrubb, SE Johansson, T Lind, ... Gastroenterology 129 (6), 1825-1831, 2005 | 995 | 2005 |
| Gastroduodenal disorders V Stanghellini, FKL Chan, WL Hasler, JR Malagelada, H Suzuki, J Tack, ... Gastroenterology 150 (6), 1380-1392, 2016 | 948 | 2016 |
| Epidemiology of colonic symptoms and the irritable bowel syndrome NJ Talley, AR Zinsmeister, C Van Dyke, LJ Melton III Gastroenterology 101 (4), 927-934, 1991 | 871 | 1991 |
| The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review P Moayyedi, AC Ford, NJ Talley, F Cremonini, AE Foxx-Orenstein, ... Gut 59 (3), 325-332, 2010 | 858 | 2010 |
| Functional dyspepsia: a classification with guidelines for diagnosis and management NJ Talley Gastroenterology International 4, 145-160, 1991 | 801* | 1991 |
| Identification of sub-groups of functional gastrointestinal disorders DA Drossman, WG Thompson, NJ Talley, P Funch-Jensen, J Janssens, ... Gastroenterology international 3 (4), 159-172, 1990 | 790 | 1990 |
| Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis AC Ford, NJ Talley, PS Schoenfeld, EMM Quigley, P Moayyedi Gut 58 (3), 367-378, 2009 | 755 | 2009 |
| Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis AC Ford, NJ Talley, BMR Spiegel, AE Foxx-Orenstein, L Schiller, ... Bmj 337, 2008 | 749 | 2008 |
| Guidelines for the management of dyspepsia NJ Talley, N Vakil, ... Official journal of the American College of Gastroenterology| ACG 100 (10 …, 2005 | 726 | 2005 |
| Immune activation in patients with irritable bowel syndrome T Liebregts, B Adam, C Bredack, A Röth, S Heinzel, S Lester, ... Gastroenterology 132 (3), 913-920, 2007 | 724 | 2007 |
